NS-229 is currently being evaluated in a phase 2 trial in patients with eosinophilic granulomatosis with polyangiitis. The Food and Drug Administration (FDA) has granted Orphan Drug designation to ...

1) Bell, CF., Lau, M., Shen, Q. Clinical and Economic Characteristics of Patients Diagnosed with Eosinophilic Granulomatosis with Polyangiitis (EGPA, formerly Churg-Strauss Syndrome) in the United ...

The London producer and DJ has put together a comprehensive collection of songs from the electronic music scene, including the likes of Pariah, Mount Kimbie and DJ Rashad Earlier this month (April ...

The nursing workforce crisis has improved slightly since the pandemic, but it’s far from over. New research from the National Council of State Boards of Nursing (NCSBN) shows that nurses are ...

National Parks Week is here once again, and this year you can enjoy the annual fee-free visits with a set of specially themed “playlists!” While they are not literal ‘playlists’ of music ...

The healthcare industry has faced a flurry of sweeping changes at the federal level since President Donald Trump took office. In recent months, healthcare leaders have scrambled to come up with ...

Depemokimab is a follow-up to GSK's Nucala (mepolizumab), a once-monthly IL-5 inhibitor approved for severe asthma, CRSwNP, eosinophilic granulomatosis with polyangiitis (EGPA), and ...